US20040220446A1 - Constriction device including tear resistant structures - Google Patents
Constriction device including tear resistant structures Download PDFInfo
- Publication number
- US20040220446A1 US20040220446A1 US10/859,819 US85981904A US2004220446A1 US 20040220446 A1 US20040220446 A1 US 20040220446A1 US 85981904 A US85981904 A US 85981904A US 2004220446 A1 US2004220446 A1 US 2004220446A1
- Authority
- US
- United States
- Prior art keywords
- ribs
- sleeve
- pattern
- lung
- tear resistance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000013013 elastic material Substances 0.000 claims abstract description 10
- 239000010432 diamond Substances 0.000 claims abstract description 5
- 229910003460 diamond Inorganic materials 0.000 abstract description 2
- 230000001902 propagating effect Effects 0.000 abstract description 2
- 210000004072 lung Anatomy 0.000 description 60
- 210000001519 tissue Anatomy 0.000 description 52
- 238000000034 method Methods 0.000 description 18
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 13
- 239000000463 material Substances 0.000 description 10
- 210000000038 chest Anatomy 0.000 description 9
- 210000002345 respiratory system Anatomy 0.000 description 8
- 238000011038 discontinuous diafiltration by volume reduction Methods 0.000 description 6
- 238000001356 surgical procedure Methods 0.000 description 6
- 238000002271 resection Methods 0.000 description 5
- 230000008901 benefit Effects 0.000 description 4
- 230000002787 reinforcement Effects 0.000 description 4
- 208000000059 Dyspnea Diseases 0.000 description 3
- 206010013975 Dyspnoeas Diseases 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 238000001050 pharmacotherapy Methods 0.000 description 3
- 229920002635 polyurethane Polymers 0.000 description 3
- 239000004814 polyurethane Substances 0.000 description 3
- 230000009325 pulmonary function Effects 0.000 description 3
- 230000000241 respiratory effect Effects 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- 206010014561 Emphysema Diseases 0.000 description 2
- 210000000621 bronchi Anatomy 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 238000002054 transplantation Methods 0.000 description 2
- 208000030507 AIDS Diseases 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 206010054949 Metaplasia Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 206010041899 Stab wound Diseases 0.000 description 1
- 206010047924 Wheezing Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 210000001008 atrial appendage Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229940125388 beta agonist Drugs 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 210000003123 bronchiole Anatomy 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 229940124630 bronchodilator Drugs 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- -1 corticosteroids Chemical class 0.000 description 1
- 229960001334 corticosteroids Drugs 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 210000002175 goblet cell Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 229960001361 ipratropium bromide Drugs 0.000 description 1
- KEWHKYJURDBRMN-ZEODDXGYSA-M ipratropium bromide hydrate Chemical compound O.[Br-].O([C@H]1C[C@H]2CC[C@@H](C1)[N@@+]2(C)C(C)C)C(=O)C(CO)C1=CC=CC=C1 KEWHKYJURDBRMN-ZEODDXGYSA-M 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000004199 lung function Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000015689 metaplastic ossification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 230000008816 organ damage Effects 0.000 description 1
- 230000002611 ovarian Effects 0.000 description 1
- 238000002640 oxygen therapy Methods 0.000 description 1
- 210000004923 pancreatic tissue Anatomy 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 208000037821 progressive disease Diseases 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 210000003019 respiratory muscle Anatomy 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 239000004945 silicone rubber Substances 0.000 description 1
- 230000005586 smoking cessation Effects 0.000 description 1
- 230000029547 smooth muscle hypertrophy Effects 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000000779 thoracic wall Anatomy 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 230000002861 ventricular Effects 0.000 description 1
- 238000004260 weight control Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/122—Clamps or clips, e.g. for the umbilical cord
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2002/043—Bronchi
Definitions
- the present invention is generally directed to a constriction device that constricts body tissue.
- the present invention is more particularly directed to a constriction device that includes tear resistant structures to preclude propagation of a tear in the device for protecting the integrity of the constriction device.
- Constriction devices have been contemplated for constricting body tissue. Such devices have been considered for use, for example, in tissue resection procedures and in treating pulmonary disease.
- COPD is a progressive disease and currently has no cure.
- Current treatments for COPD include the prevention of further respiratory damage, pharmacotherapy, and surgery. Each is discussed below.
- Pharmacotherapy may include bronchodilator therapy to open up the airways as much as possible or inhaled ⁇ -agonists. For those patients who respond poorly to the foregoing or who have persistent symptoms, Ipratropium bromide may be indicated. Further, courses of steroids, such as corticosteroids, may be required. Lastly, antibiotics may be required to prevent infections and influenza and pheumococcal vaccines may be routinely administered. Unfortunately, there is no evidence that early, regular use of pharmacotherapy will alter the progression of COPD.
- Lung transplantation is also an option.
- COPD is the most common diagnosis for which lung transplantation is considered.
- this consideration is given for only those with advanced COPD.
- lung transplant is far from being available to all patients.
- Improvements in pulmonary function after LVRS have been attributed to at least four possible mechanisms. These include enhanced elastic recoil, correction of ventilation/perfusion mismatch, improved efficiency of respiratory musculature, and improved right ventricular filling.
- Air leaks in lungs can be caused by other causes. With increasing age, a patient may develop a weakened section of lung which may then rupture due to an extreme pressure differential, such as may result from simply a hard sneeze. AIDS patients can sufferer from air leaks in their lungs. Air leaks in lungs can further be caused by a puncture from a broken rib or a stab wound.
- the invention disclosed and claimed in copending U.S. application Ser. No. 09/534,244, incorporated herein by reference, provides an improved therapy for treating COPD and air leaks in lungs.
- the therapy includes a constriction device which, when deployed on a lung, suppresses air leaks in the lung tissue without requiring any suturing of the effected lung tissue. Still further, by constricting a large enough portion of a lung with the device, lung volume reduction with the concomitant improved pulmonary function may be obtained without the need for any suturing of lung tissue at all.
- the lung constriction device includes a jacket or sheath of flexible material configured to cover at least a portion of a lung.
- the jacket has a pair of opened ends to permit the lung portion to be drawn into the jacket.
- the jacket is dimensioned to constrict the lung portion after the lung portion is drawn therein.
- the lung constriction device is preferably formed of expandable, such as elastic, material for receiving the lung tissue while the device is in an expanded or enlarged condition, and then contractible about the lung portion upon release of the expanded condition for constricting the lung tissue.
- Devices and methods similar to those disclosed in U.S. application Ser. No. 09/534,244 may be employed to advantage in other and different procedures such as in general resection procedures and for body tissue other than lung tissue.
- Resection procedures are commonly performed for such body tissue as, for example, atrial appendage tissue, ovarian tissue, gall bladder tissue, pancreatic tissue, appendix tissue and spleen tissue.
- Resection procedures may be required to treat cancer, organ damage, or organ disease, for example.
- U.S. application Ser. No. 09/534,244 also discloses and claims various methods and apparatus for deploying the constricting device on body tissue such as lung tissue.
- One apparatus and method contemplates mechanically expanding the device in a transverse dimension while physically pulling the tissue to be constricted into the device.
- Another method contemplates mounting the device over a vacuum chamber and pulling the tissue into the vacuum chamber by engaging the tissue with an opened end of the chamber and then drawing a vacuum in the chamber. This draws the tissue into the chamber. Then, the chamber is withdrawn from the device, leaving the tissue constricted in the device.
- a further method contemplates inserting the device into a vacuum chamber and sealing the opened end of the chamber to the device. The opened end of the chamber and the tissue are then brought into sealing engagement. A vacuum is next pulled in the chamber and the device to pull the tissue into the device and chamber. Once the tissue is within the device, the chamber is removed from over the device leaving the tissue constricted in the device.
- constriction devices may become dislodged due to the nature of the soft tissue on which they are deployed. More specifically, soft body tissue has a tendency to expand at the proximal end of the device causing longitudinal slippage of the device on the body tissue. This may eventually lead to the device slipping totally free from the tissue.
- One disclosed device includes a plurality of fixation elements on the inner surface of the sleeve that grasp the body tissue upon release of the sleeve from the expanded condition. More particularly, the fixation elements are adjacent to one of the opposed openings and arranged in a side-by-side relation to grasp the body tissue between adjacent fixation elements when the sleeve is released from the expanded condition.
- the fixation elements may be integral to the longitudinal side wall or adhered to the inner surface of the sleeve. Still further, the inner surfaces of the fixation elements may have roughened surfaces to further assist in grasping the constricted body tissue.
- fixation structures disclosed and claimed in the aforementioned U.S. application Ser. No. 09/902,821 are believed to be sufficient alone for maintaining the constriction device on the constricted body tissue, other forms of fixation may be further employed alone or in combination with the above described fixation structures for maintaining the constriction device on the constricted body tissue.
- fixation structures disclosed and claimed in the aforementioned U.S. application Ser. No. 09/902,821 are believed to be sufficient alone for maintaining the constriction device on the constricted body tissue
- fixation structures disclosed and claimed in the aforementioned U.S. application Ser. No. 09/902,821 are believed to be sufficient alone for maintaining the constriction device on the constricted body tissue
- fixation structures disclosed and claimed in the aforementioned U.S. application Ser. No. 09/902,821 are believed to be sufficient alone for maintaining the constriction device on the constricted body tissue
- Other forms of fixation may be further employed alone or in combination with the above described fixation structures for maintaining the constriction
- the device has an increased thickness about each suture hole to reinforce the suture holes.
- the increased thickness may have a tapered cross section for guiding a suture needle into the suture holes and may extend from the inner surface of the device or from the outer surface of the device.
- suture hole reinforcement represents an important advancement towards protecting the constriction device against tears during suturing, there is still the possibility that the device may be accidentally punctured or torn outside of a suture hole during deployment. Since, as previously mentioned, the device takes the form of a sleeve formed of relatively thin elastic material, still further tear resistance would be helpful for protecting against tear propagation. The present invention provides such additional tear propagation protection.
- the present invention provides a constriction device that is tear resistant.
- the device includes an elongated sleeve having at least one opened end and being formed from elastic material to receive, when in an expanded condition, body tissue to be constricted and to constrict the body tissue when released from the expanded condition.
- the device further includes a tear resistance structure about the sleeve that precludes propagation of a tear in the sleeve.
- the tear resistance structure may be an increased thickness of the sleeve defining a plurality of ribs in the sleeve.
- the plurality of ribs may include a first plurality of ribs and a second plurality of ribs which intersect each other.
- the intersecting ribs may define a pattern of squares, a pattern of diamonds, a pattern including waves, or a knurled pattern.
- the ribs are formed on an inner surface of the sleeve.
- the present invention further provides a constriction device that constricts body tissue, the device including sleeve means formed of elastic material including at least one opened end for constricting body tissue received therein and tear resistance means about the sleeve for precluding propagation of a tear in the sleeve means.
- FIG. 1 is a simplified sectional view of a thorax illustrating a respiratory system having a constricting device embodying the present invention deployed on a portion of a lung to effect lung volume reduction;
- FIG. 2 is a sectional view similar to FIG. 1 but illustrating the respiratory system after the constricted lung portion has been resectioned;
- FIG. 3 is a perspective view illustrating a constricting device embodying the present invention.
- FIG. 4 is a perspective view of the interior of the device of FIG. 3 illustrating a tear resistance structure embodying the present invention
- FIG. 5 is a plan view of one tear resistance structure pattern embodying the present invention.
- FIG. 6 is a plan view of another tear resistance structure pattern configured in accordance with another embodiment of the present invention.
- FIG. 7 is a further plan view of still another tear resistance structure pattern embodying the present invention.
- FIG. 8 is a still further plan view of another tear resistance structure pattern embodying the present invention.
- FIG. 1 it is a sectional view of a respiratory system 20 .
- the respiratory system 20 resides within the thorax 22 which occupies a space defined by the chest wall 24 and the diaphragm 26 .
- the respiratory system 20 includes the trachea 28 , the left mainstem bronchus 30 , the right mainstem bronchus 32 , and the bronchial branches 34 , 36 , 38 , 40 , and 42 .
- the respiratory system 20 further includes left lung lobes 52 and 54 and right lung lobes 56 , 58 , and 60 .
- Each bronchial branch communicates with a respective different portion of a lung lobe, either the entire lung lobe or a portion thereof.
- a healthy respiratory system has an arched or inwardly arcuate diaphragm 26 .
- the diaphragm 26 straightens to increase the volume of the thorax 22 . This causes a negative pressure within the thorax.
- the negative pressure within the thorax in turn causes the lung lobes to fill with air to an inflated condition.
- the diaphragm returns to its original arched condition to decrease the volume of the thorax.
- the decreased volume of the thorax causes a positive pressure within the thorax which in turn causes exhalation of the lung lobes.
- FIG. 1 also shows a constriction device 70 embodying the present invention deployed on lobe 58 .
- the device 70 is configured as a sleeve or sheath formed of a sheet of elastic biocompatible material.
- the material may be formed from silicone rubber, polyurethane, expanded polytetraflouroethylene, polyester and polyurethane, or nylon and polyurethane, for example.
- the sleeve is preferably opened at both ends and may be generally cylindrical in configuration.
- the sleeve may be applied to the lung lobe while in an expanded condition. This may be accomplished by expanding the sleeve with a vacuum and then pulling the lung portion into the sleeve with the vacuum. When the lung portion is within the sleeve, the expansion of the device is released. With the expansion released, the sleeve is permitted to contract or collapse about the lung portion to constrict the lung portion.
- the device 70 may be employed, for example, to suppress air leakages in lungs. It may also find use to advantage in constricting a lung portion suffering from COPD to simulate or achieve lung volume reduction. All of the beneficial effects of lung volume reduction surgery may be realized and, most importantly, without requiring suturing of lung tissue.
- the constriction device 70 is sutured to the constricted lung tissue by a suture 71 .
- the device 70 preferably includes a plurality of suture holes reinforced in accordance with one of the embodiments described in the aforementioned pending U.S. application Ser. No. 09/969,949 so that neither the suture needle nor the suture tears or adversely affects the integrity of the device 70 .
- FIG. 2 shows the respiratory system 20 after the constricted lung portion has been resectioned.
- the device 70 is preferably formed of severable material, such as, any of the materials previously described. This enables the device 70 to be severed or cut intermediate its ends with a suitable bladed instrument to resection the lung lobe 58 . The portion of the device 70 remaining on the lobe 58 continues to constrict the lung tissue therein to form an effective seal from leakage. The suture 71 continues to maintain the device 70 on the remaining constricted tissue. Hence, lung volume reduction is rendered an available treatment while negating the need of conventional lung sectioning and avoiding the potentially severe complications which accompany such a procedure.
- FIGS. 3 and 4 illustrate a constriction device 110 embodying the present invention.
- the device 110 is a generally cylindrical sleeve 111 having a longitudinal dimension 112 and a transverse dimension 114 .
- the device 110 is preferably formed of a relatively thin elastic material permitting the device to expand in the longitudinal dimension and more importantly in the transverse dimension.
- the device 110 may be formed from silicone.
- the device 110 has opposed opened ends 116 and 118 .
- the device may further include at one end, for example, end 118 , an integral rim 120 .
- the device 110 further includes a plurality of suture holes 122 .
- the suture holes 122 are preferably distributed about the device closely adjacent the opened end 118 .
- a suture hole reinforcement structure 124 is about each suture hole 122 .
- the suture hole reinforcement structure 124 of each suture hole 122 is an increased thickness or thickened portion in the sleeve wall forming a ring shaped structure about each suture hole on the inner surface 130 of the sleeve 111 .
- the reinforcement structure 124 of each suture hole 122 may further define a tapered surface to help guide a suture needle through its corresponding suture hole.
- the device 110 further includes a plurality of fixation elements 132 .
- the fixation elements are arranged in side-by-side relation and project inwardly from the inner surface 130 of the sleeve 111 .
- adjacent fixation elements 132 grasp the body tissue upon deployment of the sleeve to further maintain the device 110 on the constricted body tissue.
- the device 110 includes a tear resistance structure 134 .
- the tear resistance structure 134 in accordance with this embodiment, is an increased thickness in the sleeve 111 defining a plurality of ribs or ridges including a first plurality 136 of ribs and second plurality 138 of ribs.
- the ribs 136 and 138 are formed on the inner surface 130 of the sleeve 111 .
- the ribs are further arranged so that the first plurality 136 and second plurality 138 of ribs intersect each other.
- the ribs intersect to form a pattern of rectangles.
- the rib pattern circumscribes the sleeve 111 .
- any nick or tear will be precluded from propagating beyond the ribs or ridges enclosing the nick or tear.
- the overall integrity of the device 110 is protected notwithstanding an accidental or inadvertent nick or tear in the elastic material of the sleeve 111 .
- FIG. 5 shows another pattern in which the tear resistance ribs may be formed.
- first and second pluralities 150 and 152 of ribs intersect to form a diamond pattern.
- Other patterns are shown in FIGS. 6-8.
- first and second pluralities 154 and 156 of ribs intersect to form a pattern of squares.
- the ribs form a knurled pattern 158 .
- a first plurality 160 of ribs form a pattern of waves which intersect a second plurality 162 of substantially parallel ribs.
- other rib patterns may be used without departing from the present invention.
Landscapes
- Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Prostheses (AREA)
- Surgical Instruments (AREA)
Abstract
A constriction device that constricts body tissue and is formed of relatively thin elastic material includes a tear resistance structure to preclude an inadvertent tear in the device from propagating through the device. The tear resistance structure includes a plurality of intersecting ribs formed in the elastic material. The ribs circumscribe the device and define rectangular, square, diamond, wavy, or knurled patterns.
Description
- The present application is a continuation of U.S. application Ser. No. 10/394,299, filed on Mar. 21, 2003, which is a continuation of U.S. application Ser. No. 10/041,907, filed on Oct. 18, 2001, now U.S. Pat. No. 6,589,161, and claims priority benefit under 35 U.S.C. § 120. The present application also incorporates the foregoing disclosures by reference.
- 1. Field of the Invention
- The present invention is generally directed to a constriction device that constricts body tissue. The present invention is more particularly directed to a constriction device that includes tear resistant structures to preclude propagation of a tear in the device for protecting the integrity of the constriction device.
- 2. Description of the Related Art
- Constriction devices have been contemplated for constricting body tissue. Such devices have been considered for use, for example, in tissue resection procedures and in treating pulmonary disease.
- Chronic Obstructive Pulmonary Disease (COPD) has become a major cause of morbidity and mortality in the United States over the last three decades. COPD is characterized by the presence of airflow obstruction due to chronic bronchitis or emphysema. The airflow obstruction in COPD is due largely to structure abnormalities in the smaller airways. Important causes are inflammation, fibrosis, goblet cell metaplasia, and smooth muscle hypertrophy in terminal bronchioles.
- The incidence, prevalence, and health-related costs of COPD are on the rise. In 1991, COPD was the fourth leading cause of death in the United States and had increased 33% since 1979.
- COPD affects the patient's whole life. It has three main symptoms: cough; breathlessness; and wheeze. At first, breathlessness may be noticed when running for a bus, digging in the garden, or walking up hill. Later, it may be noticed when simply walking in the kitchen. Over time, it may occur with less and less effort until it is present all of the time.
- COPD is a progressive disease and currently has no cure. Current treatments for COPD include the prevention of further respiratory damage, pharmacotherapy, and surgery. Each is discussed below.
- The prevention of further respiratory damage entails the adoption of a healthy lifestyle. Smoking cessation is believed to be the single most important therapeutic intervention. However, regular exercise and weight control are also important. Patients whose symptoms restrict their daily activities or who otherwise have an impaired quality of life may require a pulmonary rehabilitation program including ventilatory muscle training and breathing retraining. Long-term oxygen therapy may also become necessary.
- Pharmacotherapy may include bronchodilator therapy to open up the airways as much as possible or inhaled β-agonists. For those patients who respond poorly to the foregoing or who have persistent symptoms, Ipratropium bromide may be indicated. Further, courses of steroids, such as corticosteroids, may be required. Lastly, antibiotics may be required to prevent infections and influenza and pheumococcal vaccines may be routinely administered. Unfortunately, there is no evidence that early, regular use of pharmacotherapy will alter the progression of COPD.
- Lung transplantation is also an option. Today, COPD is the most common diagnosis for which lung transplantation is considered. Unfortunately, this consideration is given for only those with advanced COPD. Given the limited availability of donor organs, lung transplant is far from being available to all patients.
- About 40 years ago, it was first postulated that the tethering force that tends to keep the intrathoracic airways open was lost in emphysema and that by surgically removing the most affected parts' of the lungs, the force could be partially restored. Although the surgery was deemed promising, the procedure was abandoned.
- The lung volume reduction surgery (LVRS) was later revived. In the early 1990's, hundreds of patients underwent the procedure. However, the procedure has fallen out of favor due to the act that Medicare stopped remitting for LVRS. Unfortunately, data is relatively scarce and many factors conspire to make what data exists difficult to interpret. The procedure is currently under review in a controlled clinical trial. However, what data does exist tends to indicate that patients benefited from the procedure in terms of an increase in forced expiratory volume, a decrease in total lung capacity, and a significant improvement in lung function, dyspnea, and quality of life.
- Improvements in pulmonary function after LVRS have been attributed to at least four possible mechanisms. These include enhanced elastic recoil, correction of ventilation/perfusion mismatch, improved efficiency of respiratory musculature, and improved right ventricular filling.
- The improvements in pulmonary function resulting from LVRS cannot be ignored. However, the surgery is very invasive and fraught with complications. Among the complications is the potential for lung air leaks. Lung tissue is very thin and fragile, hence difficult to suture together. After a lung portion is sectioned and removed, the remaining lung is most often restructured with suture staples. In about thirty percent (30%) of the cases, the difficulty with suturing lung tissue results in air leaks. Treatment for such air leaks depends upon their severity and often, in the most serious cases, requires further open chest surgery.
- Air leaks in lungs can be caused by other causes. With increasing age, a patient may develop a weakened section of lung which may then rupture due to an extreme pressure differential, such as may result from simply a hard sneeze. AIDS patients can sufferer from air leaks in their lungs. Air leaks in lungs can further be caused by a puncture from a broken rib or a stab wound.
- The invention disclosed and claimed in copending U.S. application Ser. No. 09/534,244, incorporated herein by reference, provides an improved therapy for treating COPD and air leaks in lungs. The therapy includes a constriction device which, when deployed on a lung, suppresses air leaks in the lung tissue without requiring any suturing of the effected lung tissue. Still further, by constricting a large enough portion of a lung with the device, lung volume reduction with the concomitant improved pulmonary function may be obtained without the need for any suturing of lung tissue at all.
- The lung constriction device includes a jacket or sheath of flexible material configured to cover at least a portion of a lung. The jacket has a pair of opened ends to permit the lung portion to be drawn into the jacket. The jacket is dimensioned to constrict the lung portion after the lung portion is drawn therein. The lung constriction device is preferably formed of expandable, such as elastic, material for receiving the lung tissue while the device is in an expanded or enlarged condition, and then contractible about the lung portion upon release of the expanded condition for constricting the lung tissue.
- An important aspect of the device and method disclosed in U.S. application Ser. No. 09/534,244 is the ability to sever the constricting device intermediate its ends. This allows a significant portion of the constricted lung tissue to be removed altogether while permitting a portion of the constricting device to remain in the body for continued suppression of air leaks and maintenance of the remaining lung tissue integrity.
- Devices and methods similar to those disclosed in U.S. application Ser. No. 09/534,244 may be employed to advantage in other and different procedures such as in general resection procedures and for body tissue other than lung tissue. Resection procedures are commonly performed for such body tissue as, for example, atrial appendage tissue, ovarian tissue, gall bladder tissue, pancreatic tissue, appendix tissue and spleen tissue. Resection procedures may be required to treat cancer, organ damage, or organ disease, for example.
- U.S. application Ser. No. 09/534,244 also discloses and claims various methods and apparatus for deploying the constricting device on body tissue such as lung tissue. One apparatus and method contemplates mechanically expanding the device in a transverse dimension while physically pulling the tissue to be constricted into the device.
- Another method contemplates mounting the device over a vacuum chamber and pulling the tissue into the vacuum chamber by engaging the tissue with an opened end of the chamber and then drawing a vacuum in the chamber. This draws the tissue into the chamber. Then, the chamber is withdrawn from the device, leaving the tissue constricted in the device.
- A further method contemplates inserting the device into a vacuum chamber and sealing the opened end of the chamber to the device. The opened end of the chamber and the tissue are then brought into sealing engagement. A vacuum is next pulled in the chamber and the device to pull the tissue into the device and chamber. Once the tissue is within the device, the chamber is removed from over the device leaving the tissue constricted in the device.
- Although various methods and apparatus have been conceived for effectively deploying constriction devices on body tissue, the constriction devices, over time, may become dislodged due to the nature of the soft tissue on which they are deployed. More specifically, soft body tissue has a tendency to expand at the proximal end of the device causing longitudinal slippage of the device on the body tissue. This may eventually lead to the device slipping totally free from the tissue.
- To meet the needs for fixation, U.S. application Ser. No. 09/902,821, filed Jul. 10, 2001, and incorporated herein by reference, discloses and claims a constriction device having positive fixation structure for maintaining the constriction device deployed on the body tissue.
- One disclosed device includes a plurality of fixation elements on the inner surface of the sleeve that grasp the body tissue upon release of the sleeve from the expanded condition. More particularly, the fixation elements are adjacent to one of the opposed openings and arranged in a side-by-side relation to grasp the body tissue between adjacent fixation elements when the sleeve is released from the expanded condition. The fixation elements may be integral to the longitudinal side wall or adhered to the inner surface of the sleeve. Still further, the inner surfaces of the fixation elements may have roughened surfaces to further assist in grasping the constricted body tissue.
- While the fixation structures disclosed and claimed in the aforementioned U.S. application Ser. No. 09/902,821 are believed to be sufficient alone for maintaining the constriction device on the constricted body tissue, other forms of fixation may be further employed alone or in combination with the above described fixation structures for maintaining the constriction device on the constricted body tissue. One additional form of fixation widely practiced in the medical field is suturing.
- While suturing would appear to be an option, simply suturing the constriction device to the constricted body tissue would pose a number of problems. Such problems would arise because the material from which the constriction device is formed is relatively thin elastic material. The suturing of such material could easily cause tearing of the device by the suture. Moreover, the very act of puncturing the device material with a suture needle could readily cause tearing of the device material. Copending U.S. application Ser. No. 09/969,949 filed Oct. 2, 2001 and incorporated herein by reference discloses a constriction device configured to permit the suturing of the device to constricted body tissue while protecting against tearing of the device material by either the suture or a suture needle.
- In one disclosed embodiment, the device has an increased thickness about each suture hole to reinforce the suture holes. The increased thickness may have a tapered cross section for guiding a suture needle into the suture holes and may extend from the inner surface of the device or from the outer surface of the device.
- While the suture hole reinforcement mentioned above represents an important advancement towards protecting the constriction device against tears during suturing, there is still the possibility that the device may be accidentally punctured or torn outside of a suture hole during deployment. Since, as previously mentioned, the device takes the form of a sleeve formed of relatively thin elastic material, still further tear resistance would be helpful for protecting against tear propagation. The present invention provides such additional tear propagation protection.
- The present invention provides a constriction device that is tear resistant. The device includes an elongated sleeve having at least one opened end and being formed from elastic material to receive, when in an expanded condition, body tissue to be constricted and to constrict the body tissue when released from the expanded condition. The device further includes a tear resistance structure about the sleeve that precludes propagation of a tear in the sleeve.
- The tear resistance structure may be an increased thickness of the sleeve defining a plurality of ribs in the sleeve. The plurality of ribs may include a first plurality of ribs and a second plurality of ribs which intersect each other. The intersecting ribs may define a pattern of squares, a pattern of diamonds, a pattern including waves, or a knurled pattern. Preferably the ribs are formed on an inner surface of the sleeve.
- The present invention further provides a constriction device that constricts body tissue, the device including sleeve means formed of elastic material including at least one opened end for constricting body tissue received therein and tear resistance means about the sleeve for precluding propagation of a tear in the sleeve means.
- The features of the present invention which are believed to be novel are set forth with particularity in the appended claims. The invention, together with further objects and advantages thereof, may best be understood by making reference to the following description taken in conjunction with the accompanying drawings, in the several figures of which like reference numerals identify identical elements, and wherein:
- FIG. 1 is a simplified sectional view of a thorax illustrating a respiratory system having a constricting device embodying the present invention deployed on a portion of a lung to effect lung volume reduction;
- FIG. 2 is a sectional view similar to FIG. 1 but illustrating the respiratory system after the constricted lung portion has been resectioned;
- FIG. 3 is a perspective view illustrating a constricting device embodying the present invention;
- FIG. 4 is a perspective view of the interior of the device of FIG. 3 illustrating a tear resistance structure embodying the present invention;
- FIG. 5 is a plan view of one tear resistance structure pattern embodying the present invention;
- FIG. 6 is a plan view of another tear resistance structure pattern configured in accordance with another embodiment of the present invention;
- FIG. 7 is a further plan view of still another tear resistance structure pattern embodying the present invention; and
- FIG. 8 is a still further plan view of another tear resistance structure pattern embodying the present invention.
- Referring now to FIG. 1, it is a sectional view of a
respiratory system 20. Therespiratory system 20 resides within thethorax 22 which occupies a space defined by thechest wall 24 and thediaphragm 26. - The
respiratory system 20 includes thetrachea 28, theleft mainstem bronchus 30, theright mainstem bronchus 32, and thebronchial branches respiratory system 20 further includesleft lung lobes right lung lobes - A healthy respiratory system has an arched or inwardly
arcuate diaphragm 26. As the individual inhales, thediaphragm 26 straightens to increase the volume of thethorax 22. This causes a negative pressure within the thorax. The negative pressure within the thorax in turn causes the lung lobes to fill with air to an inflated condition. When the individual exhales, the diaphragm returns to its original arched condition to decrease the volume of the thorax. The decreased volume of the thorax causes a positive pressure within the thorax which in turn causes exhalation of the lung lobes. - FIG. 1 also shows a
constriction device 70 embodying the present invention deployed onlobe 58. Thedevice 70 is configured as a sleeve or sheath formed of a sheet of elastic biocompatible material. The material may be formed from silicone rubber, polyurethane, expanded polytetraflouroethylene, polyester and polyurethane, or nylon and polyurethane, for example. The sleeve is preferably opened at both ends and may be generally cylindrical in configuration. - The sleeve may be applied to the lung lobe while in an expanded condition. This may be accomplished by expanding the sleeve with a vacuum and then pulling the lung portion into the sleeve with the vacuum. When the lung portion is within the sleeve, the expansion of the device is released. With the expansion released, the sleeve is permitted to contract or collapse about the lung portion to constrict the lung portion.
- The
device 70 may be employed, for example, to suppress air leakages in lungs. It may also find use to advantage in constricting a lung portion suffering from COPD to simulate or achieve lung volume reduction. All of the beneficial effects of lung volume reduction surgery may be realized and, most importantly, without requiring suturing of lung tissue. Theconstriction device 70 is sutured to the constricted lung tissue by asuture 71. To that end, thedevice 70 preferably includes a plurality of suture holes reinforced in accordance with one of the embodiments described in the aforementioned pending U.S. application Ser. No. 09/969,949 so that neither the suture needle nor the suture tears or adversely affects the integrity of thedevice 70. - FIG. 2 shows the
respiratory system 20 after the constricted lung portion has been resectioned. Thedevice 70 is preferably formed of severable material, such as, any of the materials previously described. This enables thedevice 70 to be severed or cut intermediate its ends with a suitable bladed instrument to resection thelung lobe 58. The portion of thedevice 70 remaining on thelobe 58 continues to constrict the lung tissue therein to form an effective seal from leakage. Thesuture 71 continues to maintain thedevice 70 on the remaining constricted tissue. Hence, lung volume reduction is rendered an available treatment while negating the need of conventional lung sectioning and avoiding the potentially severe complications which accompany such a procedure. - FIGS. 3 and 4 illustrate a
constriction device 110 embodying the present invention. As generally illustrated in FIG. 3, thedevice 110 is a generallycylindrical sleeve 111 having alongitudinal dimension 112 and atransverse dimension 114. As previously mentioned, thedevice 110 is preferably formed of a relatively thin elastic material permitting the device to expand in the longitudinal dimension and more importantly in the transverse dimension. For example, thedevice 110 may be formed from silicone. Thedevice 110 has opposed opened ends 116 and 118. The device may further include at one end, for example, end 118, anintegral rim 120. - The
device 110 further includes a plurality of suture holes 122. The suture holes 122 are preferably distributed about the device closely adjacent the openedend 118. About eachsuture hole 122 is a suturehole reinforcement structure 124. The suturehole reinforcement structure 124 of eachsuture hole 122 is an increased thickness or thickened portion in the sleeve wall forming a ring shaped structure about each suture hole on theinner surface 130 of thesleeve 111. Thereinforcement structure 124 of eachsuture hole 122 may further define a tapered surface to help guide a suture needle through its corresponding suture hole. - As may be best seen in FIG. 4, the
device 110 further includes a plurality offixation elements 132. The fixation elements are arranged in side-by-side relation and project inwardly from theinner surface 130 of thesleeve 111. As described in the aforementioned U.S. application Ser. No. 09/902,821,adjacent fixation elements 132 grasp the body tissue upon deployment of the sleeve to further maintain thedevice 110 on the constricted body tissue. - With continued reference to FIG. 4, and in accordance with the present invention, the
device 110 includes atear resistance structure 134. Thetear resistance structure 134, in accordance with this embodiment, is an increased thickness in thesleeve 111 defining a plurality of ribs or ridges including afirst plurality 136 of ribs andsecond plurality 138 of ribs. Theribs inner surface 130 of thesleeve 111. The ribs are further arranged so that thefirst plurality 136 andsecond plurality 138 of ribs intersect each other. Here, the ribs intersect to form a pattern of rectangles. The rib pattern circumscribes thesleeve 111. By virtue of the tear resistance structure of the rib pattern, any nick or tear will be precluded from propagating beyond the ribs or ridges enclosing the nick or tear. As a result, the overall integrity of thedevice 110 is protected notwithstanding an accidental or inadvertent nick or tear in the elastic material of thesleeve 111. - FIG. 5 shows another pattern in which the tear resistance ribs may be formed. Here, first and
second pluralities second pluralities knurled pattern 158. In FIG. 8, afirst plurality 160 of ribs form a pattern of waves which intersect asecond plurality 162 of substantially parallel ribs. As will be appreciated by those skilled in the art, other rib patterns may be used without departing from the present invention. - [53] While the invention has been described by means of specific embodiments and applications thereof, it is understood that numerous modifications and variations could be made thereto by those skilled in the art without departing from the spirit and scope of the invention. It is therefore to be understood that within the scope of the claims, the invention may be practiced otherwise than as specifically described herein.
Claims (20)
1. A constriction device that constricts body tissue, the device comprising:
an elongated sleeve including at least one opened end and being formed from elastic material to receive, when in an expanded condition, body tissue to be constricted and to constrict the body tissue when released from the expanded condition; and
a tear resistance structure about the sleeve that precludes propagation of a tear in the sleeve.
2. The device of claim 1 wherein the tear resistance structure is an increased thickness of the sleeve.
3. The device of claim 1 wherein the tear resistance structure is a plurality of ribs in the sleeve.
4. The device of claim 3 wherein the plurality of ribs include a first plurality of ribs and a second plurality of ribs and wherein the first and second pluralities of ribs intersect each other.
5. The device of claim 4 wherein the first and second pluralities of ribs intersect each other to form a pattern of squares.
6. The device of claim 4 wherein the first and second pluralities of ribs intersect each other to form a pattern of diamonds.
7. The device of claim 4 wherein one of the first and second pluralities of ribs forms a pattern of waves.
8. The device of claim 7 wherein the pattern of waves is circumferential about the sleeve.
9. The device of claim 3 wherein the plurality of ribs forms a knurl pattern.
10. The device of claim 1 wherein the tear resistance structure is on an inner surface of the sleeve.
11. A constriction device that constricts body tissue, the device comprising:
sleeve means formed of elastic material including at least one opened end of constricting body tissue received therein; and
tear resistance means about the sleeve for precluding propagation of a tear in the sleeve means.
12. The device of claim 11 wherein the tear resistance means is an increased thickness of the sleeve.
13. The device of claim 11 wherein the tear resistance means is a plurality of ribs in the sleeve.
14. The device of claim 13 wherein the plurality of ribs include a first plurality of ribs and a second plurality of ribs and wherein the first and second pluralities of ribs intersect each other.
15. The device of claim 14 wherein the first and second pluralities of ribs intersect each other to form a pattern of squares.
16. The device of claim 14 wherein the first and second pluralities of ribs intersect each other to form a pattern of diamonds.
17. The device of claim 14 wherein one of the first and second pluralities of ribs forms a pattern of waves.
18. The device of claim 17 wherein the pattern of waves is circumferential about the sleeve.
19. The device of claim 13 wherein the plurality of ribs forms a knurl pattern.
20. The device of claim 11 wherein the tear resistance means is on an inner surface of the sleeve.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/859,819 US20040220446A1 (en) | 2001-10-18 | 2004-06-02 | Constriction device including tear resistant structures |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/041,907 US6589161B2 (en) | 2001-10-18 | 2001-10-18 | Constriction device including tear resistant structures |
US10/394,299 US6843767B2 (en) | 2001-10-18 | 2003-03-21 | Constriction device including tear resistant structures |
US10/859,819 US20040220446A1 (en) | 2001-10-18 | 2004-06-02 | Constriction device including tear resistant structures |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/394,299 Continuation US6843767B2 (en) | 2001-10-18 | 2003-03-21 | Constriction device including tear resistant structures |
Publications (1)
Publication Number | Publication Date |
---|---|
US20040220446A1 true US20040220446A1 (en) | 2004-11-04 |
Family
ID=21918985
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/041,907 Expired - Lifetime US6589161B2 (en) | 2001-10-18 | 2001-10-18 | Constriction device including tear resistant structures |
US10/394,299 Expired - Fee Related US6843767B2 (en) | 2001-10-18 | 2003-03-21 | Constriction device including tear resistant structures |
US10/859,819 Abandoned US20040220446A1 (en) | 2001-10-18 | 2004-06-02 | Constriction device including tear resistant structures |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/041,907 Expired - Lifetime US6589161B2 (en) | 2001-10-18 | 2001-10-18 | Constriction device including tear resistant structures |
US10/394,299 Expired - Fee Related US6843767B2 (en) | 2001-10-18 | 2003-03-21 | Constriction device including tear resistant structures |
Country Status (6)
Country | Link |
---|---|
US (3) | US6589161B2 (en) |
EP (1) | EP1435871A4 (en) |
JP (1) | JP2005506129A (en) |
AU (1) | AU2002353813B2 (en) |
CA (1) | CA2463515A1 (en) |
WO (1) | WO2003032864A2 (en) |
Cited By (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7682332B2 (en) | 2003-07-15 | 2010-03-23 | Portaero, Inc. | Methods to accelerate wound healing in thoracic anastomosis applications |
US7686013B2 (en) | 2006-01-17 | 2010-03-30 | Portaero, Inc. | Variable resistance pulmonary ventilation bypass valve |
US7753052B2 (en) | 2003-06-05 | 2010-07-13 | Portaero, Inc. | Intra-thoracic collateral ventilation bypass system |
US7789083B2 (en) | 2003-05-20 | 2010-09-07 | Portaero, Inc. | Intra/extra thoracic system for ameliorating a symptom of chronic obstructive pulmonary disease |
US7811274B2 (en) | 2003-05-07 | 2010-10-12 | Portaero, Inc. | Method for treating chronic obstructive pulmonary disease |
US7824366B2 (en) | 2004-12-10 | 2010-11-02 | Portaero, Inc. | Collateral ventilation device with chest tube/evacuation features and method |
US7896008B2 (en) | 2003-06-03 | 2011-03-01 | Portaero, Inc. | Lung reduction system |
US7909803B2 (en) | 2008-02-19 | 2011-03-22 | Portaero, Inc. | Enhanced pneumostoma management device and methods for treatment of chronic obstructive pulmonary disease |
US7931641B2 (en) | 2007-05-11 | 2011-04-26 | Portaero, Inc. | Visceral pleura ring connector |
US8062315B2 (en) | 2007-05-17 | 2011-11-22 | Portaero, Inc. | Variable parietal/visceral pleural coupling |
US8104474B2 (en) | 2005-08-23 | 2012-01-31 | Portaero, Inc. | Collateral ventilation bypass system with retention features |
US8163034B2 (en) | 2007-05-11 | 2012-04-24 | Portaero, Inc. | Methods and devices to create a chemically and/or mechanically localized pleurodesis |
US8220460B2 (en) | 2004-11-19 | 2012-07-17 | Portaero, Inc. | Evacuation device and method for creating a localized pleurodesis |
US8336540B2 (en) | 2008-02-19 | 2012-12-25 | Portaero, Inc. | Pneumostoma management device and method for treatment of chronic obstructive pulmonary disease |
US8347881B2 (en) | 2009-01-08 | 2013-01-08 | Portaero, Inc. | Pneumostoma management device with integrated patency sensor and method |
US8475389B2 (en) | 2008-02-19 | 2013-07-02 | Portaero, Inc. | Methods and devices for assessment of pneumostoma function |
US8518053B2 (en) | 2009-02-11 | 2013-08-27 | Portaero, Inc. | Surgical instruments for creating a pneumostoma and treating chronic obstructive pulmonary disease |
US10470839B2 (en) | 2016-06-02 | 2019-11-12 | Covidien Lp | Assessment of suture or staple line integrity and localization of potential tissue defects along the suture or staple line |
Families Citing this family (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6997189B2 (en) * | 1998-06-05 | 2006-02-14 | Broncus Technologies, Inc. | Method for lung volume reduction |
US6886098B1 (en) * | 1999-08-13 | 2005-04-26 | Microsoft Corporation | Systems and methods for compression of key sets having multiple keys |
US6328689B1 (en) | 2000-03-23 | 2001-12-11 | Spiration, Inc., | Lung constriction apparatus and method |
US6491706B1 (en) * | 2001-07-10 | 2002-12-10 | Spiration, Inc. | Constriction device including fixation structure |
US6994706B2 (en) | 2001-08-13 | 2006-02-07 | Minnesota Medical Physics, Llc | Apparatus and method for treatment of benign prostatic hyperplasia |
US6589161B2 (en) * | 2001-10-18 | 2003-07-08 | Spiration, Inc. | Constriction device including tear resistant structures |
US7533667B2 (en) * | 2003-05-29 | 2009-05-19 | Portaero, Inc. | Methods and devices to assist pulmonary decompression |
WO2005122870A2 (en) | 2004-06-14 | 2005-12-29 | Pneumrx, Inc. | Lung access device |
EP3542736A1 (en) * | 2004-06-16 | 2019-09-25 | PneumRx, Inc. | Intra-bronchial lung volume reduction system |
US7766891B2 (en) | 2004-07-08 | 2010-08-03 | Pneumrx, Inc. | Lung device with sealing features |
WO2006014567A2 (en) | 2004-07-08 | 2006-02-09 | Pneumrx, Inc. | Pleural effusion treatment device, method and material |
US20060118126A1 (en) * | 2004-11-19 | 2006-06-08 | Don Tanaka | Methods and devices for controlling collateral ventilation |
US7398782B2 (en) * | 2004-11-19 | 2008-07-15 | Portaero, Inc. | Method for pulmonary drug delivery |
WO2006058195A2 (en) | 2004-11-23 | 2006-06-01 | Pneumrx, Inc. | Steerable device for accessing a target site and methods |
US20060217972A1 (en) * | 2005-03-28 | 2006-09-28 | Tellabs Operations, Inc. | Method and apparatus for modifying an encoded signal |
US8721734B2 (en) | 2009-05-18 | 2014-05-13 | Pneumrx, Inc. | Cross-sectional modification during deployment of an elongate lung volume reduction device |
US8157837B2 (en) | 2006-03-13 | 2012-04-17 | Pneumrx, Inc. | Minimally invasive lung volume reduction device and method |
US8888800B2 (en) | 2006-03-13 | 2014-11-18 | Pneumrx, Inc. | Lung volume reduction devices, methods, and systems |
US9402633B2 (en) | 2006-03-13 | 2016-08-02 | Pneumrx, Inc. | Torque alleviating intra-airway lung volume reduction compressive implant structures |
US20080281151A1 (en) * | 2007-05-11 | 2008-11-13 | Portaero, Inc. | Pulmonary pleural stabilizer |
US20080283065A1 (en) * | 2007-05-15 | 2008-11-20 | Portaero, Inc. | Methods and devices to maintain patency of a lumen in parenchymal tissue of the lung |
US20080287878A1 (en) * | 2007-05-15 | 2008-11-20 | Portaero, Inc. | Pulmonary visceral pleura anastomosis reinforcement |
US20080295829A1 (en) * | 2007-05-30 | 2008-12-04 | Portaero, Inc. | Bridge element for lung implant |
US9867652B2 (en) | 2008-04-29 | 2018-01-16 | Virginia Tech Intellectual Properties, Inc. | Irreversible electroporation using tissue vasculature to treat aberrant cell masses or create tissue scaffolds |
US10702326B2 (en) | 2011-07-15 | 2020-07-07 | Virginia Tech Intellectual Properties, Inc. | Device and method for electroporation based treatment of stenosis of a tubular body part |
US10272178B2 (en) | 2008-04-29 | 2019-04-30 | Virginia Tech Intellectual Properties Inc. | Methods for blood-brain barrier disruption using electrical energy |
US9283051B2 (en) | 2008-04-29 | 2016-03-15 | Virginia Tech Intellectual Properties, Inc. | System and method for estimating a treatment volume for administering electrical-energy based therapies |
US10238447B2 (en) | 2008-04-29 | 2019-03-26 | Virginia Tech Intellectual Properties, Inc. | System and method for ablating a tissue site by electroporation with real-time monitoring of treatment progress |
US11254926B2 (en) | 2008-04-29 | 2022-02-22 | Virginia Tech Intellectual Properties, Inc. | Devices and methods for high frequency electroporation |
EP2280741A4 (en) | 2008-04-29 | 2012-06-13 | Virginia Tech Intell Prop | Irreversible electroporation to create tissue scaffolds |
US11272979B2 (en) | 2008-04-29 | 2022-03-15 | Virginia Tech Intellectual Properties, Inc. | System and method for estimating tissue heating of a target ablation zone for electrical-energy based therapies |
US10448989B2 (en) | 2009-04-09 | 2019-10-22 | Virginia Tech Intellectual Properties, Inc. | High-frequency electroporation for cancer therapy |
US9198733B2 (en) | 2008-04-29 | 2015-12-01 | Virginia Tech Intellectual Properties, Inc. | Treatment planning for electroporation-based therapies |
US10117707B2 (en) | 2008-04-29 | 2018-11-06 | Virginia Tech Intellectual Properties, Inc. | System and method for estimating tissue heating of a target ablation zone for electrical-energy based therapies |
US8992517B2 (en) | 2008-04-29 | 2015-03-31 | Virginia Tech Intellectual Properties Inc. | Irreversible electroporation to treat aberrant cell masses |
US10245098B2 (en) | 2008-04-29 | 2019-04-02 | Virginia Tech Intellectual Properties, Inc. | Acute blood-brain barrier disruption using electrical energy based therapy |
US9173669B2 (en) | 2008-09-12 | 2015-11-03 | Pneumrx, Inc. | Enhanced efficacy lung volume reduction devices, methods, and systems |
US11382681B2 (en) | 2009-04-09 | 2022-07-12 | Virginia Tech Intellectual Properties, Inc. | Device and methods for delivery of high frequency electrical pulses for non-thermal ablation |
US11638603B2 (en) | 2009-04-09 | 2023-05-02 | Virginia Tech Intellectual Properties, Inc. | Selective modulation of intracellular effects of cells using pulsed electric fields |
WO2010138919A2 (en) | 2009-05-28 | 2010-12-02 | Angiodynamics, Inc. | System and method for synchronizing energy delivery to the cardiac rhythm |
US9895189B2 (en) | 2009-06-19 | 2018-02-20 | Angiodynamics, Inc. | Methods of sterilization and treating infection using irreversible electroporation |
ES2811027T3 (en) * | 2010-02-19 | 2021-03-10 | Lifecell Corp | Devices for the treatment of the abdominal wall |
US8425455B2 (en) | 2010-03-30 | 2013-04-23 | Angiodynamics, Inc. | Bronchial catheter and method of use |
WO2012051433A2 (en) | 2010-10-13 | 2012-04-19 | Angiodynamics, Inc. | System and method for electrically ablating tissue of a patient |
US9078665B2 (en) | 2011-09-28 | 2015-07-14 | Angiodynamics, Inc. | Multiple treatment zone ablation probe |
JP6594901B2 (en) | 2014-05-12 | 2019-10-23 | バージニア テック インテレクチュアル プロパティース インコーポレイテッド | Selective modulation of intracellular effects of cells using pulsed electric fields |
US10390838B1 (en) | 2014-08-20 | 2019-08-27 | Pneumrx, Inc. | Tuned strength chronic obstructive pulmonary disease treatment |
WO2016100325A1 (en) | 2014-12-15 | 2016-06-23 | Virginia Tech Intellectual Properties, Inc. | Devices, systems, and methods for real-time monitoring of electrophysical effects during tissue treatment |
US10905492B2 (en) | 2016-11-17 | 2021-02-02 | Angiodynamics, Inc. | Techniques for irreversible electroporation using a single-pole tine-style internal device communicating with an external surface electrode |
US11607537B2 (en) | 2017-12-05 | 2023-03-21 | Virginia Tech Intellectual Properties, Inc. | Method for treating neurological disorders, including tumors, with electroporation |
US11311329B2 (en) | 2018-03-13 | 2022-04-26 | Virginia Tech Intellectual Properties, Inc. | Treatment planning for immunotherapy based treatments using non-thermal ablation techniques |
US11925405B2 (en) | 2018-03-13 | 2024-03-12 | Virginia Tech Intellectual Properties, Inc. | Treatment planning system for immunotherapy enhancement via non-thermal ablation |
CA3096883A1 (en) * | 2018-04-12 | 2019-10-17 | Axogen Corporation | Tissue grafts with pre-made attachment points |
US11950835B2 (en) | 2019-06-28 | 2024-04-09 | Virginia Tech Intellectual Properties, Inc. | Cycled pulsing to mitigate thermal damage for multi-electrode irreversible electroporation therapy |
US11576666B2 (en) | 2019-10-04 | 2023-02-14 | Arthrex, Inc | Surgical constructs for tissue fixation and methods of tissue repairs |
Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2816542A (en) * | 1955-03-17 | 1957-12-17 | Richard B Freeman | Prophylactic tube with differential wall thickness |
US4895140A (en) * | 1988-08-08 | 1990-01-23 | C.P.S. Inc. | Device for overcoming male dysfunction or impotence |
US5350388A (en) * | 1989-03-07 | 1994-09-27 | Albert Einstein College Of Medicine Of Yeshiva University | Hemostasis apparatus and method |
US5509891A (en) * | 1994-12-19 | 1996-04-23 | Deridder; Paul A. | Prothesis for male dysfunction |
US5592950A (en) * | 1995-02-24 | 1997-01-14 | Alberto Kopelowicz | Latex prophylactics |
US5816249A (en) * | 1996-04-30 | 1998-10-06 | Kopelowicz; Alberto | Latex prophylactics adhered to a deformed knitted fabric and their manufacturing procedure |
US6077214A (en) * | 1998-07-29 | 2000-06-20 | Myocor, Inc. | Stress reduction apparatus and method |
US6193648B1 (en) * | 1999-09-21 | 2001-02-27 | Acorn Cardiovascular, Inc. | Cardiac constraint with draw string tensioning |
US6224564B1 (en) * | 1998-06-05 | 2001-05-01 | Leon Korobow | Elastic elbow brace |
US6514290B1 (en) * | 2000-03-31 | 2003-02-04 | Broncus Technologies, Inc. | Lung elastic recoil restoring or tissue compressing device and method |
US6589161B2 (en) * | 2001-10-18 | 2003-07-08 | Spiration, Inc. | Constriction device including tear resistant structures |
US6632239B2 (en) * | 2001-10-02 | 2003-10-14 | Spiration, Inc. | Constriction device including reinforced suture holes |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4685534A (en) * | 1983-08-16 | 1987-08-11 | Burstein A Lincoln | Method and apparatus for control of fluids |
US4738249A (en) * | 1985-03-01 | 1988-04-19 | The Procter & Gamble Company | Method and apparatus for augmenting blood circulation |
GB8927282D0 (en) * | 1989-12-01 | 1990-01-31 | Univ Strathclyde | Vascular surgical devices |
US5711760A (en) * | 1993-03-15 | 1998-01-27 | Englewood Research Associates | Self-inflating venous boot |
DE4405831C2 (en) * | 1994-02-23 | 1996-09-05 | Karlsruhe Forschzent | Bags for the intracorporeal introduction of organs, organ parts or tissue complexes into the bag and for the extraction thereof |
DE69637293T2 (en) * | 1995-02-17 | 2008-08-07 | Reid, Tony, Santa Cruz | DEVICE FOR TREATING OILS |
US6061840A (en) * | 1998-02-13 | 2000-05-16 | Alligator; Squire | Men's anatomic underwear/swimwear |
US6059797A (en) * | 1998-06-17 | 2000-05-09 | Ensurg, Inc. | Self-disposing ligating band dispenser |
US6076013A (en) * | 1999-01-14 | 2000-06-13 | Brennan; Edward F. | Apparatus and methods for treating congestive heart failure |
US6328689B1 (en) * | 2000-03-23 | 2001-12-11 | Spiration, Inc., | Lung constriction apparatus and method |
US6453903B1 (en) * | 2001-07-13 | 2002-09-24 | Thomas, Iii Kirtis | Condom with constrictive band about opening |
-
2001
- 2001-10-18 US US10/041,907 patent/US6589161B2/en not_active Expired - Lifetime
-
2002
- 2002-10-15 AU AU2002353813A patent/AU2002353813B2/en not_active Ceased
- 2002-10-15 WO PCT/US2002/032886 patent/WO2003032864A2/en active Application Filing
- 2002-10-15 EP EP02789202A patent/EP1435871A4/en not_active Withdrawn
- 2002-10-15 CA CA002463515A patent/CA2463515A1/en not_active Abandoned
- 2002-10-15 JP JP2003535671A patent/JP2005506129A/en not_active Withdrawn
-
2003
- 2003-03-21 US US10/394,299 patent/US6843767B2/en not_active Expired - Fee Related
-
2004
- 2004-06-02 US US10/859,819 patent/US20040220446A1/en not_active Abandoned
Patent Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2816542A (en) * | 1955-03-17 | 1957-12-17 | Richard B Freeman | Prophylactic tube with differential wall thickness |
US4895140A (en) * | 1988-08-08 | 1990-01-23 | C.P.S. Inc. | Device for overcoming male dysfunction or impotence |
US5350388A (en) * | 1989-03-07 | 1994-09-27 | Albert Einstein College Of Medicine Of Yeshiva University | Hemostasis apparatus and method |
US5509891A (en) * | 1994-12-19 | 1996-04-23 | Deridder; Paul A. | Prothesis for male dysfunction |
US5592950A (en) * | 1995-02-24 | 1997-01-14 | Alberto Kopelowicz | Latex prophylactics |
US5816249A (en) * | 1996-04-30 | 1998-10-06 | Kopelowicz; Alberto | Latex prophylactics adhered to a deformed knitted fabric and their manufacturing procedure |
US6224564B1 (en) * | 1998-06-05 | 2001-05-01 | Leon Korobow | Elastic elbow brace |
US6077214A (en) * | 1998-07-29 | 2000-06-20 | Myocor, Inc. | Stress reduction apparatus and method |
US6193648B1 (en) * | 1999-09-21 | 2001-02-27 | Acorn Cardiovascular, Inc. | Cardiac constraint with draw string tensioning |
US6514290B1 (en) * | 2000-03-31 | 2003-02-04 | Broncus Technologies, Inc. | Lung elastic recoil restoring or tissue compressing device and method |
US6632239B2 (en) * | 2001-10-02 | 2003-10-14 | Spiration, Inc. | Constriction device including reinforced suture holes |
US6589161B2 (en) * | 2001-10-18 | 2003-07-08 | Spiration, Inc. | Constriction device including tear resistant structures |
US6843767B2 (en) * | 2001-10-18 | 2005-01-18 | Spiration, Inc. | Constriction device including tear resistant structures |
Cited By (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8029492B2 (en) | 2003-05-07 | 2011-10-04 | Portaero, Inc. | Method for treating chronic obstructive pulmonary disease |
US7828789B2 (en) | 2003-05-07 | 2010-11-09 | Portaero, Inc. | Device and method for creating a localized pleurodesis and treating a lung through the localized pleurodesis |
US7811274B2 (en) | 2003-05-07 | 2010-10-12 | Portaero, Inc. | Method for treating chronic obstructive pulmonary disease |
US7789083B2 (en) | 2003-05-20 | 2010-09-07 | Portaero, Inc. | Intra/extra thoracic system for ameliorating a symptom of chronic obstructive pulmonary disease |
US7896008B2 (en) | 2003-06-03 | 2011-03-01 | Portaero, Inc. | Lung reduction system |
US7753052B2 (en) | 2003-06-05 | 2010-07-13 | Portaero, Inc. | Intra-thoracic collateral ventilation bypass system |
US8323230B2 (en) | 2003-07-15 | 2012-12-04 | Portaero, Inc. | Methods and devices to accelerate wound healing in thoracic anastomosis applications |
US7682332B2 (en) | 2003-07-15 | 2010-03-23 | Portaero, Inc. | Methods to accelerate wound healing in thoracic anastomosis applications |
US8220460B2 (en) | 2004-11-19 | 2012-07-17 | Portaero, Inc. | Evacuation device and method for creating a localized pleurodesis |
US7824366B2 (en) | 2004-12-10 | 2010-11-02 | Portaero, Inc. | Collateral ventilation device with chest tube/evacuation features and method |
US8104474B2 (en) | 2005-08-23 | 2012-01-31 | Portaero, Inc. | Collateral ventilation bypass system with retention features |
US7726305B2 (en) | 2006-01-17 | 2010-06-01 | Portaero, Inc. | Variable resistance pulmonary ventilation bypass valve |
US7686013B2 (en) | 2006-01-17 | 2010-03-30 | Portaero, Inc. | Variable resistance pulmonary ventilation bypass valve |
US8163034B2 (en) | 2007-05-11 | 2012-04-24 | Portaero, Inc. | Methods and devices to create a chemically and/or mechanically localized pleurodesis |
US7931641B2 (en) | 2007-05-11 | 2011-04-26 | Portaero, Inc. | Visceral pleura ring connector |
US8062315B2 (en) | 2007-05-17 | 2011-11-22 | Portaero, Inc. | Variable parietal/visceral pleural coupling |
US8231581B2 (en) | 2008-02-19 | 2012-07-31 | Portaero, Inc. | Enhanced pneumostoma management device and methods for treatment of chronic obstructive pulmonary disease |
US8365722B2 (en) | 2008-02-19 | 2013-02-05 | Portaero, Inc. | Multi-layer pneumostoma management system and methods for treatment of chronic obstructive pulmonary disease |
US7927324B2 (en) | 2008-02-19 | 2011-04-19 | Portaero, Inc. | Aspirator and method for pneumostoma management |
US8252003B2 (en) | 2008-02-19 | 2012-08-28 | Portaero, Inc. | Surgical instruments for creating a pneumostoma and treating chronic obstructive pulmonary disease |
US7909803B2 (en) | 2008-02-19 | 2011-03-22 | Portaero, Inc. | Enhanced pneumostoma management device and methods for treatment of chronic obstructive pulmonary disease |
US8336540B2 (en) | 2008-02-19 | 2012-12-25 | Portaero, Inc. | Pneumostoma management device and method for treatment of chronic obstructive pulmonary disease |
US8506577B2 (en) | 2008-02-19 | 2013-08-13 | Portaero, Inc. | Two-phase surgical procedure for creating a pneumostoma to treat chronic obstructive pulmonary disease |
US8348906B2 (en) | 2008-02-19 | 2013-01-08 | Portaero, Inc. | Aspirator for pneumostoma management |
US8347880B2 (en) | 2008-02-19 | 2013-01-08 | Potaero, Inc. | Pneumostoma management system with secretion management features for treatment of chronic obstructive pulmonary disease |
US8021320B2 (en) | 2008-02-19 | 2011-09-20 | Portaero, Inc. | Self-sealing device and method for delivery of a therapeutic agent through a pneumostoma |
US8430094B2 (en) | 2008-02-19 | 2013-04-30 | Portaero, Inc. | Flexible pneumostoma management system and methods for treatment of chronic obstructive pulmonary disease |
US8453638B2 (en) | 2008-02-19 | 2013-06-04 | Portaero, Inc. | One-piece pneumostoma management system and methods for treatment of chronic obstructive pulmonary disease |
US8453637B2 (en) | 2008-02-19 | 2013-06-04 | Portaero, Inc. | Pneumostoma management system for treatment of chronic obstructive pulmonary disease |
US8464708B2 (en) | 2008-02-19 | 2013-06-18 | Portaero, Inc. | Pneumostoma management system having a cosmetic and/or protective cover |
US8475389B2 (en) | 2008-02-19 | 2013-07-02 | Portaero, Inc. | Methods and devices for assessment of pneumostoma function |
US8474449B2 (en) | 2008-02-19 | 2013-07-02 | Portaero, Inc. | Variable length pneumostoma management system for treatment of chronic obstructive pulmonary disease |
US8491602B2 (en) | 2008-02-19 | 2013-07-23 | Portaero, Inc. | Single-phase surgical procedure for creating a pneumostoma to treat chronic obstructive pulmonary disease |
US8347881B2 (en) | 2009-01-08 | 2013-01-08 | Portaero, Inc. | Pneumostoma management device with integrated patency sensor and method |
US8518053B2 (en) | 2009-02-11 | 2013-08-27 | Portaero, Inc. | Surgical instruments for creating a pneumostoma and treating chronic obstructive pulmonary disease |
US10470839B2 (en) | 2016-06-02 | 2019-11-12 | Covidien Lp | Assessment of suture or staple line integrity and localization of potential tissue defects along the suture or staple line |
Also Published As
Publication number | Publication date |
---|---|
US6589161B2 (en) | 2003-07-08 |
US20030078469A1 (en) | 2003-04-24 |
AU2002353813A2 (en) | 2003-04-28 |
WO2003032864A2 (en) | 2003-04-24 |
JP2005506129A (en) | 2005-03-03 |
EP1435871A2 (en) | 2004-07-14 |
US6843767B2 (en) | 2005-01-18 |
US20030163024A1 (en) | 2003-08-28 |
EP1435871A4 (en) | 2006-04-12 |
AU2002353813B2 (en) | 2008-04-17 |
CA2463515A1 (en) | 2003-04-24 |
WO2003032864A3 (en) | 2003-10-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6589161B2 (en) | Constriction device including tear resistant structures | |
AU2002362449B2 (en) | Constriction device including reinforced suture holes | |
AU2002353813A1 (en) | Constriction device including tear resistant structures | |
US6491706B1 (en) | Constriction device including fixation structure | |
AU2002362449A1 (en) | Constriction device including reinforced suture holes | |
EP1078601B1 (en) | Kit for lung volume reduction | |
US6860847B2 (en) | Constriction device viewable under X ray fluoroscopy | |
US6328689B1 (en) | Lung constriction apparatus and method | |
US6592594B2 (en) | Bronchial obstruction device deployment system and method | |
AU2002329218A1 (en) | Constriction device including fixation structure | |
AU2002354640A1 (en) | Construction device viewable under X ray fluoroscopy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |
|
AS | Assignment |
Owner name: GYRUS ACMI, INC., MASSACHUSETTS Free format text: MERGER;ASSIGNOR:SPIRATION, INC.;REEL/FRAME:052401/0484 Effective date: 20200401 |